Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy

Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy

Thumbnail Image
Download
Name

11904_2022_625_ReferencePDF.pdf

Size

704.64 KB

Format

Adobe PDF

Checksum (MD5)

a313c883308e65ac4ec5538a265729ee

Download all files submitted through automated deposit
art_5393357601804367133.zip (627.63 KB)
Author(s)
Goodman, Georgia R.
•
Vaz, Clint
•
Albrechta, Hannah
•
Boyer, Edward W.
•
Mayer, Kenneth H.
•
O’Cleirigh, Conall
•
Chai, Peter R.
Date Issued
September 1, 2022
Publisher
Springer US
Citation
Goodman, Georgia R., Vaz, Clint, Albrechta, Hannah, Boyer, Edward W., Mayer, Kenneth H. et al. 2022. "Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy."
Version
Author's final manuscript
Abstract
Abstract Purpose of Review This review summarizes the recent advancements and future directions of digital pill systems (DPS) — which utilize ingestible sensors to directly measure medication ingestion events in real-time — in the context of HIV prevention and treatment. Recent Findings Two DPS are cleared by the US Food and Drug Administration. The bioequivalence and stability of digitized pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) have been established, and pilot studies have demonstrated the feasibility and acceptability of using DPS for PrEP and ART adherence measurement. Important bioethical and implementation considerations have been identified for future clinical trials. Continued technological advancement may reduce barriers to use, and integration of DPS into behavioral interventions may facilitate adherence improvement efforts. Summary DPS represent an innovative tool for PrEP and ART adherence measurement. Future work will optimize the technology to reduce operational barriers. DPS have significant potential for expansion across a diverse array of diseases, though key bioethical considerations must be examined prior to large-scale implementation.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/145567
DOI of Published Version
https://doi.org/10.1007/s11904-022-00625-x
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.